Adjuvant bevacizumab: positive data from a negative trial

Lancet Oncol. 2013 Sep;14(10):910-1. doi: 10.1016/S1470-2045(13)70378-4. Epub 2013 Aug 7.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bevacizumab
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab